Abstract:Technological advances and high-throughput bio-chemical assays are rapidly changing ways how we formulate and test biological hypotheses, and how we treat patients. Most complex diseases arise on a background of genetics, lifestyle and environment factors, and manifest themselves as a spectrum of symptoms. To fathom intricate biological processes and their changes from healthy to disease states, we need to systematically integrate and analyze multi-omics datasets, ontologies, and diverse annotations. Without proper management of such complex biological and clinical data, artificial intelligence (AI) algorithms alone cannot be effectively trained, validated, and successfully applied to provide trustworthy and patient-centric diagnosis, prognosis and treatment. Precision medicine requires to use multi-omics approaches effectively, and offers many opportunities for using AI, "big data" analytics, and integrative computational biology workflows. Advances in optical and biochemical assay technologies including sequencing, mass spectrometry and imaging modalities have transformed research by empowering us to simultaneously view all genes expressed, identify proteome-wide changes, and assess interacting partners of each individual protein within a dynamically changing biological system, at an individual cell level. While such views are already having an impact on our understanding of healthy and disease conditions, it remains challenging to extract useful information comprehensively and systematically from individual studies, ensure that signal is separated from noise, develop models, and provide hypotheses for further research. Data remain incomplete and are often poorly connected using fragmented biological networks. In addition, statistical and machine learning models are developed at a cohort level and often not validated at the individual patient level. Combining integrative computational biology and AI has the potential to improve understanding and treatment of diseases by identifying biomarkers and building explainable models characterizing individual patients. From systematic data analysis to more specific diagnostic, prognostic and predictive biomarkers, drug mechanism of action, and patient selection, such analyses influence multiple steps from prevention to disease characterization, and from prognosis to drug discovery. Data mining, machine learning, graph theory and advanced visualization may help identify diagnostic, prognostic and predictive biomarkers, and create causal models of disease. Intertwining computational prediction and modeling with biological experiments leads to faster, more biologically and clinically relevant discoveries. However, computational analysis results and models are going to be only as accurate and useful as correct and comprehensive are the networks, ontologies and datasets used to build them. High quality, curated data portals provide the necessary foundation for translational research. They help to identify better biomarkers, new drugs, precision treatments, and should lead to improved patient outcomes and their quality of life. Intertwining computational prediction and modeling with biological experiments, efficiently and effectively leads to more useful findings faster.

Leveraging AI for improved reproducibility of mathematical disease models: insights from a retinitis pigmentosa case study

Explainable biology for improved therapies in precision medicine: AI is not enough

Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models

A Model-Based Reinforcement Learning Approach for a Rare Disease Diagnostic Task

In Silico Treatment: a computational framework for animal model selection and drug assessment

Robustness and reproducibility for AI learning in biomedical sciences: RENOIR

Machine Learning in Modeling Disease Trajectory and Treatment Outcomes: An Emerging Enabler for Model‐Informed Precision Medicine

The Impact of Artificial Intelligence in the Odyssey of Rare Diseases

Replicating a High-Impact Scientific Publication Using Systems of Large Language Models

Democratizing Infectious Disease Modeling: An AI Assistant for Generating, Simulating, and Analyzing Dynamic Models

Diagnosing retinal disorders with artificial intelligence: the role of large language models in interpreting pattern electroretinography data

An Inherently Interpretable AI model improves Screening Speed and Accuracy for Early Diabetic Retinopathy

Artificial intelligence for retinal diseases

Reveal to Revise: An Explainable AI Life Cycle for Iterative Bias Correction of Deep Models

Mutation Pathogenicity Prediction by a Biology Based Explainable AI Multi-Modal Algorithm

Assessing Reusability of Deep Learning-Based Monotherapy Drug Response Prediction Models Trained with Omics Data

A model‐informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy

Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models

[The revolution of AI in drug development]

Simulate Scientific Reasoning with Multiple Large Language Models: An Application to Alzheimer's Disease Combinatorial Therapy

Leveraging Computational Pathology AI for Noninvasive Optical Imaging Analysis Without Retraining